208 related articles for article (PubMed ID: 12077582)
21. Gender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery.
Scheingraber S; Dobbert D; Schmiedel P; Seliger E; Dralle H
Surg Today; 2005; 35(10):846-54. PubMed ID: 16175466
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
23. Cytokine balance in the lungs of patients with acute respiratory distress syndrome.
Park WY; Goodman RB; Steinberg KP; Ruzinski JT; Radella F; Park DR; Pugin J; Skerrett SJ; Hudson LD; Martin TR
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1896-903. PubMed ID: 11734443
[TBL] [Abstract][Full Text] [Related]
24. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
25. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin.
Skov L; Hansen H; Allen M; Villadsen L; Norval M; Barker JN; Simon J; Baadsgaard O
Br J Dermatol; 1998 Feb; 138(2):216-20. PubMed ID: 9602863
[TBL] [Abstract][Full Text] [Related]
26. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
Wang F; He D; Tang X; Zhang X
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
[TBL] [Abstract][Full Text] [Related]
27. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients.
Wesseldijk F; Huygen FJ; Heijmans-Antonissen C; Niehof SP; Zijlstra FJ
Eur J Pain; 2008 Aug; 12(6):716-21. PubMed ID: 18055234
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
Gaultier F; Ejeil AL; Igondjo-Tchen S; Dohan D; Dridi SM; Maman L; Wierzba CB; Stania D; Pellat B; Lafont A; Godeau G; Gogly B
Arch Dermatol Res; 2004 Oct; 296(5):220-5. PubMed ID: 15449075
[TBL] [Abstract][Full Text] [Related]
30. Crystal-clear blister fluid with low albumin concentration during toxic epidermal necrolysis.
Contou D; Flores-Paraire L; Ortonne N; Chosidow O; de Prost N
Burns; 2016 Sep; 42(6):1360-1. PubMed ID: 27338179
[No Abstract] [Full Text] [Related]
31. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
32. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo.
Shahbakhti H; Watson RE; Azurdia RM; Ferreira CZ; Garmyn M; Rhodes LE
Photochem Photobiol; 2004; 80(2):231-5. PubMed ID: 15362934
[TBL] [Abstract][Full Text] [Related]
33. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
[TBL] [Abstract][Full Text] [Related]
35. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
36. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
[TBL] [Abstract][Full Text] [Related]
37. Photo-induced toxic epidermal necrolysis caused by clobazam.
Redondo P; Vicente J; España A; Subira ML; De Felipe I; Quintanilla E
Br J Dermatol; 1996 Dec; 135(6):999-1002. PubMed ID: 8977728
[TBL] [Abstract][Full Text] [Related]
38. Diverse expression of TNF-α and CCL27 in serum and blister of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang F; Ye Y; Luo ZY; Gao Q; Luo DQ; Zhang X
Clin Transl Allergy; 2018; 8():12. PubMed ID: 29713456
[TBL] [Abstract][Full Text] [Related]
39. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.
Paquet P; Paquet F; Al Saleh W; Reper P; Vanderkelen A; Piérard GE
Am J Dermatopathol; 2000 Oct; 22(5):413-7. PubMed ID: 11048976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
